Healthy New Jersey

Cannabis Regulatory Commission

NJ-CRC by the Numbers

Posted on - 04/20/2023
Share on Social :
NJ-CRC by the Numbers

April 12, 2023, marked the second anniversary of the New Jersey Cannabis Regulatory Commission.  Over the last two years, we’ve held dozens of public meetings, worked with the public to develop rules for adult-use cannabis business, increased the number of medicinal dispensaries and saw the first sale of recreational cannabis on April 21st, 2022. To commemorate our second anniversary, we are looking at NJ CRC by the Numbers.

Previous Blog Posts

Celebrating three years of growth and equity in NJ cannabis

Celebrating three years of growth and equity in NJ cannabis

04/22/2024

April marks the third anniversary of the New Jersey Cannabis Regulatory Commission (NJ-CRC) - a good time to take stock of the progress New Jersey’s cannabis market has made. The milestone coincides with the second anniversary of recreational sales, and the exponential growth of the industry is a testament to the collective efforts of ambitious and driven entrepreneurs, keen stakeholders, an engaged public, and dedicated employees at the NJ-CRC. These twin anniversaries are an opportunity to recognize their invaluable contributions and the evolution of New Jersey's cannabis industry.

Behind the green tape: Navigating NJ's cannabis market regulations

Behind the green tape: Navigating NJ's cannabis market regulations

04/5/2024

NJ-CRC Chief Counsel Christopher Riggs discusses the regulations that underpin the NJ cannabis market and clinical registration licenses. 

Exploring the use of cannabis to treat medical conditions that affect women

Cannabis and Women's Health

03/25/2024

"Women's health" covers a myriad of physiological systems and bodily functions unique to their biology. Addressing women’s health means treating medical conditions and challenges unique to this half of the world’s population – like maternal mortality and the menopausal transition. Cannabis is increasingly being considered part of the women’s health and well-being arsenal by the medical community. While a federal ban makes broad scientific and medical research difficult, there is some indication of potential therapeutic benefits for women. Some of the medical conditions for which cannabis may be a beneficial part of treatment are on the list of qualifying conditions for the New Jersey Medicinal Cannabis Program.


Back
to top